Specialty & Oncology November 2016
Cancer Biosimilars: Regulation Challenges and Clinical Impact
There are currently four FDA-approved biosimilars available in the United States, but only one (Zarxio) has cancer indications.
The Impact of Generic Medications on Breast Cancer Prevention
Cost savings from generic medications have significantly increased adherence rates, and the impact of these medications on breast cancer survival rates is expected to be significant.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.